Stereotaxis Inc
AMEX:STXS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Stereotaxis Inc
Accrued Liabilities
Stereotaxis Inc
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Stereotaxis Inc
AMEX:STXS
|
Accrued Liabilities
$7m
|
CAGR 3-Years
39%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Accrued Liabilities
$3.2B
|
CAGR 3-Years
23%
|
CAGR 5-Years
14%
|
CAGR 10-Years
12%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Accrued Liabilities
$1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
|
Stryker Corp
NYSE:SYK
|
Accrued Liabilities
$4.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Accrued Liabilities
$7.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accrued Liabilities
$1.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
18%
|
CAGR 10-Years
18%
|
|
Stereotaxis Inc
Glance View
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The company is headquartered in St. Louis, Missouri and currently employs 130 full-time employees. The company went IPO on 2004-08-12. The firm's robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. The firm also offers to its customers the Stereotaxis Imaging Model S X-ray System and other accessory devices. The Genesis RMN System is designed to enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites. The Odyssey Solution consolidates lab information onto an integrated display, enabling physicians to view and control all the key information in the operating room.
See Also
What is Stereotaxis Inc's Accrued Liabilities?
Accrued Liabilities
7m
USD
Based on the financial report for Dec 31, 2025, Stereotaxis Inc's Accrued Liabilities amounts to 7m USD.
What is Stereotaxis Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
1%
Over the last year, the Accrued Liabilities growth was 187%. The average annual Accrued Liabilities growth rates for Stereotaxis Inc have been 39% over the past three years , 5% over the past five years , and 1% over the past ten years .
